Medication info
Sulforase CR Sustained Release Tablet (Acebrophylline)

Sulforase CR Sustained Release Tablet (Acebrophylline)

Prescription medicationTabletOral
Ingredient · strength
Acebrophylline›200mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated sustained release tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201701042 · Approved 2017.02.24 · Insurance code 642004070

Summary

Main use
Treatment of acute bronchitis associated with airway obstruction and mucus secretion disorders
Who takes it
Adults
Adult dose
Adults: Administer 200mg (1 tablet) of acebrophylline orally once daily at a consistent time. This is an extended-release formulation; swallow it whole without splitting or crushing.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acute bronchitis associated with airway obstruction and mucus secretion disorders

  • Airway obstruction
  • mucus secretion disorder
  • acute respiratory disease
  • acute bronchitis
View approved original text

This medication is used for acute respiratory diseases, particularly acute bronchitis, caused by airway obstruction and mucus secretion disorders.

How to take

Adult dose

Adults: Administer 200mg (1 tablet) of acebrophylline orally once daily at a consistent time. This is an extended-release formulation; swallow it whole without splitting or crushing.

Precautions

This medication should not be used in certain patients. Patients who are allergic to this medication or its ingredients, or other xanthine-type medications, should not take this drug. Patients allergic to ambroxol should also refrain from using this medication. It is also advisable not to take this drug if you have acute heart damage, very low blood pressure, severe liver or kidney dysfunction, or if you are a nursing woman. Furthermore, this medication should be used with caution in patients with heart disease, congestive heart failure, obesity, a history of epilepsy, peptic ulcers, hyperthyroidism, hypertension, chronic obstructive pulmonary disease, severe hypoxia, liver or kidney dysfunction, women who are pregnant or may become pregnant, as well as elderly patients and children. During treatment with this medication, you may occasionally experience symptoms such as nausea or dizziness, and gastrointestinal symptoms such as indigestion, abdominal pain, diarrhea, constipation, vomiting, decreased appetite, and heartburn may rarely occur. In addition, allergic reactions such as rash, itching, facial swelling, and difficulty breathing require immediate cessation of the medication. This medication can be toxic if blood levels become too high; therefore, dosage adjustments are necessary for elderly patients or those with impaired liver or kidney function, or for alcoholics. Be cautious when taking this medication in conjunction with other drugs, especially certain antibiotics, anticoagulants, diuretics, and central nervous system stimulants, as they can affect the blood concentration of this medication; consultation with a physician or pharmacist is recommended. The use of this medication during pregnancy is generally not advisable unless there are exceptional cases, and it is also suggested that nursing women avoid taking this medication. Special caution is needed when administering this medication to elderly patients and children, as serious side effects can occur in cases of overdose, requiring immediate medical assistance. This medication should be kept out of reach of children, and it is safest not to transfer it to another container. It can be taken regardless of meals, although the drug concentration may slightly increase with high-fat meals, which is not clinically significant.

Side effects

  • nausea
  • dizziness
  • abdominal discomfort
  • bloating
  • abdominal pain
  • diarrhea
  • constipation
  • vomiting
  • hematemesis
  • heartburn
Show 34 more
  • loss of appetite
  • gastrointestinal bleeding
  • epigastric pain
  • rash
  • urticaria
  • urticaria-like erythema
  • itching
  • facial swelling
  • dyspnea
  • elevated body temperature
  • purulent rhinitis
  • tachypnea
  • oral paresthesia
  • arm paresthesia
  • headache
  • agitation
  • insomnia
  • tachycardia
  • ectopic beats
  • hypermobility
  • hypotension
  • albuminuria
  • hyperglycemia
  • dyspepsia
  • dry mouth
  • abdominal malaise
  • nasopharyngitis
  • oropharyngeal pain
  • rhinorrhea
  • urinary frequency
  • dermatitis
  • thirst
  • infection
  • weight gain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated sustained release tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.